The report published on Wound Cleanser Products Market is a comprehensive analysis that includes the key parameters and indicators critical in understanding the market. The data from the years 2022 to 2031 has been used to present the market status and size. The study also covers the overall market valuation along with the CAGR for the forecast period. The introductory chapter presents an overview of Wound Cleanser Products Market along with the product definition and market scope. The report also analyzes consumer trends regarding the products along with the industry development trends.
Wound cleanser products are known to remove contaminants and foreign materials such as debris on the skin surrounding the wound and the surface of the wound, and come in solutions, sprays, gels, and wipes. These cleansers are an effective means of infection control and help in preventing hospital associated infections through reduced frequency of change in dressings during treatment. This directly translates to a decrease in the unit cost in contrast to the traditional method of wound cleansing and tending.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11689
According to the latest revised report published by Persistence Market Research, the wound cleanser products market is expected to witness a CAGR of 1.5% during the forecast period (2021 – 2031), to close in on a valuation of US$ 2.4 Bn by the end of 2031.
Company Profiles:
- ConvaTec Group plc
- Smith & Nephew plc
- Reckitt Benckiser Group plc
- B.BraunMelsungen AG
- Coloplast A/S
- Becton, Dickinson and Company
- Molnlycke Healthcare
- 3M
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11689
Key Takeaways from Market Study
- The global market for wound cleanser products is expected to swell 1.4X by 2031 as compared to its current market size.
- The wetting agents segment, under product, is expected to hold more than 30% of revenue share in the market.
- By end user, hospitals hold the highest market share in 2021, with sprays acquiring a significant market share of more than 25%.
- Countries such as the U.S., Brazil, India, and China are expected to experience significant market growth over the coming years due to increase in awareness about wound cleansers and their cost-effectiveness.
- The COVID-19 outbreak has had a positive impact on demand forwound cleanser products, due to rising awareness regarding hygiene and prevention of infection through contact.
- The market in South Asia is projected to expand at the highest CAGR of 2.6%, closely followed by MEA at 2% CAGR, over the next ten years.
“Rise in cases of chronic wounds and diabetic foot ulcers is augmenting demand for wound cleanser products across the globe,” says a Persistence Market Research analyst.
Collaboration & Acquisitions – Key Strategies by Market Players
Leading wound cleanser products manufacturers are strengthening their product portfolios through collaboration and acquisitions.
- In January 2021, Integra LifeSciences completed the acquisition of ACell Inc. and its proprietary MatriStem UBM™, enabling the company to cater to complex wound management solutions in a comprehensive manner.
Various manufacturers are also focusing on growth strategies such as new product launches and FDA approvals.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/11689
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the wound cleanser products market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for the period of 2021 – 2031, based on Product type (Wetting agents, Antiseptics, Moisturizers and others), Form Type (Solutions, Sprays, Foams, Wipes and Gels), Wound Type (Acute wounds, Chronic wounds and Burns) and end-user (Hospitals, Ambulatory Surgery Centers, Clinics, Long Term Care Centers and Home Care Settings), across seven key regions.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]